Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M De Bandt

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Annals of the Rheumatic Diseases|July 5, 2005
Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of RheumatologyX Le Loët, J M Berthelot, A Cantagrel, et al.
Annals of the Rheumatic Diseases|October 20, 2007
Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in FranceT Lequerré, P Quartier, D Rosellini, et al.
Arthritis Care & Research|November 15, 2011
Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the AutoImmunity and Rituximab RegistryX Puéchal, J E Gottenberg, J M Berthelot, et al.
Clinical and Experimental Rheumatology|June 8, 2002
Differences in understanding and application of 1987 ACR criteria for rheumatoid arthritis and 1991 ESSG criteria for spondylarthropathy. A pilot surveyJ M Berthelot, H J Bernelot-Moens, M Klarlund, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Annals of the Rheumatic Diseases|July 5, 2005
Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of RheumatologyX Le Loët, J M Berthelot, A Cantagrel, et al.
Annals of the Rheumatic Diseases|October 20, 2007
Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in FranceT Lequerré, P Quartier, D Rosellini, et al.
Arthritis Care & Research|November 15, 2011
Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the AutoImmunity and Rituximab RegistryX Puéchal, J E Gottenberg, J M Berthelot, et al.
Clinical and Experimental Rheumatology|June 8, 2002
Differences in understanding and application of 1987 ACR criteria for rheumatoid arthritis and 1991 ESSG criteria for spondylarthropathy. A pilot surveyJ M Berthelot, H J Bernelot-Moens, M Klarlund, et al.
Pageof 8